Geoffrey Kim, M.D.
Vice President, Applied Innovation at BeiGene
Before becoming Vice President of Applied Innovation at BeiGene, Dr. Kim was Vice President, Oncology and Head of Oncology Strategic Combinations at AstraZeneca from July 2017 – July 2019.
He was Director, Division of Oncology Products 1, at the U. S. Food and Drug Administration from March 2015 – July 2017. Prior to that, he was a Medical Officer at the FDA.
Dr. Kim received his medical degree from New York Medical College.